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The primary aim of the present study was to evaluate the efficacy and stability over time of
a cognitive rehabilitation protocol (restorative and compensatory approach) in HIV/AIDS
patients with HIV-associated Neurocognitive Disorder (HAND). At baseline, 32 HIV/AIDS
patients (16 with and 16 without HAND) were assessed with a neuropsychological
battery (i.e., pre-assessment) consisting of 22 tests covering eight cognitive domains.
Then, the experimental group was administered over 4 months a cognitive rehabilitation
protocol aimed at improving four cognitive domains by means of eight paper and
pencil/computer-based exercises. The control group received guideline-adherent clinical
care (i.e., standard of care). At the end of the cognitive treatment, both groups were
re-administered the neuropsychological battery (i.e., post-assessment). Additionally,
6 months after post-assessment, the experimental group was given the same
neuropsychological battery (i.e., follow up-assessment). In order to test the efficacy
of the cognitive rehabilitation protocol, we compared between groups the results of
the neuropsychological battery at the pre- and post-assessments. In order to evaluate
the stability over time, the effects of the cognitive rehabilitation protocol was examined
comparing within the experimental group the results of the neuropsychological battery
at post- and follow up-assessments. Our results show that the two groups did
not differ at the pre-assessment, but differed at post-assessment. Specifically, the
experimental group showed a significant improvement in five domains (Learning and
memory, Abstraction/executive functioning, Verbal fluency, Attention/working memory,
and Functional), whereas the control group significantly worsened in the same domains.
The improvement of the experimental group did not change in the follow up-assessment
in two domains (Abstraction/executive functioning, Attention/working memory, and
Functional). Overall, these findings support the efficacy and, to some extent, the stability
over time of our cognitive rehabilitation protocol.
Keywords: HIV, cognitive impairment, HIV-associated neurocognitive disorders, neurocognitive rehabilitation,
HAND
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INTRODUCTION
Combination antiretroviral therapy has extended the survival of
patients living with Human Immunodeficiency Virus (HIV) and,
as a result, HIV is becoming a chronic disease. At the same
time, however, patients appear to be more commonly affected
by physical, social and cognitive disabilities (e.g., O’Brien et al.,
2014) than the general population. For instance, in a population-
based sample of people living with HIV, over 80% of patients
reported at least one impairment, activity limitation or social
participation restriction (Rusch et al., 2004). One of the most
common causes of disability is HIV-associated Neurocognitive
Disorder (HAND; Heaton et al., 2010). The largest HAND
study to date reported deficits in 52% of HIV-seropositive adults
(Heaton et al., 2010). Since, these disabilities can affect clinical
outcomes, cognitive rehabilitation may be a key step in the
maintenance or improvement of quality of life of HIV patients.
Consensus research criteria for classifying HAND were
published in 2007 (Antinori et al., 2007). Specifically, the authors
proposed three categories: Asymptomatic Neurocognitive
Impairment (ANI), Mild Neurocognitive Disorder (MND), and
HIV-Associated Dementia (HAD). The taxonomy is based on
objective diagnostic criteria and account for daily functioning.
The diagnosis of mild (MND) or severe (HAD) symptomatic
HAND, for instance, requires a functional decline in at least two
cognitive domains.
While the incidence of HAD has been reduced with
combination antiretroviral therapy, the prevalence of less severe
forms of neurocognitive disorders (i.e., ANI and MND) has
remained relatively stable. Further, a large longitudinal study
found that both ANI and MND were associated with cognitive
worsening (Grant et al., 2014). One explanation for the
persistence of mild HAND is antiretroviral neurotoxicity (Giunta
et al., 2011; Robertson et al., 2012). Such toxicity may occur via
direct drug effects on neurons and glia or indirectly via drug-
linked effects on other organs, such as the cardiovascular system
(Underwood et al., 2015).
The development of treatments for HAND is an important
unmet clinical need. With regard to cognitive rehabilitation,
three studies have been published to date (Boivin et al., 2010;
Becker et al., 2012; Vance et al., 2012) but none employed
HAND diagnoses as inclusion criteria and all used the so-called
restorative approach that aims to restore the neural circuits
underlying impaired cognitive processes by means of practice
and focused training exercises. These studies reported positive
effects on visual learning (Boivin et al., 2010) and speed of
information processing (Boivin et al., 2010; Vance et al., 2012).
However, the improvement did not extend to other ecologically
relevant cognitive domains, such as executive functioning or
working memory, and the durability of the benefits was not
strongly addressed.
In the present study, we aimed to examine the efficacy and
durability of a cognitive rehabilitation treatment for HAND
in HIV+ adults taking suppressive antiretroviral therapy. To
maximize the ecological impact of the training, our intervention
combined the restorative approach of prior studies with the
compensatory approach known to better enable learning of new
strategies and minimizing the impact of remaining impairment
(Robertson and Murre, 1999; Cicerone et al., 2005; Dams-
O’Connor et al., 2009). We predicted a significant improvement
of the neuropsychological picture in HAND-treated, respect
to HAND-untreated patients. Additionally, we predicted the
stability over time of these effects.
MATERIALS AND METHODS
Participants
Thirty-two patients (16 with and 16 without HAND) in
care to the Infectious Disease Unit “Division A,” Amedeo
of Savoia Hospital (Turin, Italy) provided written informed
consent to participate in the study, which was approved by
the Local Bioethics Committee (ASL TO2). The study did not
include any pharmacological intervention, and it was performed
in accordance with the ethical standards described in the
Declaration of Helsinki (World Medical Association, 2013).
Patients were randomized 1:1 to either the experimental
group or the control group. The two groups did not differ in
demographic, clinical, or treatment characteristics (all p > 0.05,
see Table 1).
Both groups were administered a pre-assessment
neuropsychological battery (see below). Then, the experimental
group was given the cognitive rehabilitation intervention
for 4 months (see below for the full description) and the
control group was given standard of care. At the end of
the cognitive treatment, both groups were re-administered
(post-assessment) the neuropsychological battery. The
experimental group was also given the neuropsychological
battery 6 months after the post-assessment (follow up) in
a within-subjects randomized order. Raw scores on each
TABLE 1 | Demographical/Clinical data of the two groups of patients and
their statistical comparisons at baseline (pre-assessment).
Experimental Control p
group group
Sample size 16 16 >0.05
Plasma HIV-RNAb (≤ 50 c/mL)2 16 16 >0.05
Years HIV infecteda 11.25 (5.8) 8.75 (6) >0.05
Current CD4+ T-cell countc 539 (299–611) 614 (369–810) >0.05
Nadir CD4 T-cell countc 212 (100–273) 177 (57–265) >0.05
HCV seropositiveb (%) 3 (19) 1 (6) >0.05
Number of current antiretroviralsc 3 (3–4) 3 (3–4) >0.05
CPE (CNS penetration
effectiveness score) of current
regimena
7.1 (2) 7.5 (1.3) >0.05
Age (years)c 47.5 (12.2) 50 (8.4) >0.05
Ethnicity (Cau)b 16 (100) 14 (87.5) >0.05
Educationc 10 (3) 9 (3.9) >0.05
Gender (Women)b 5 (31) 3 (19) >0.05
Mean (SD) Median (IQR) or Number (%).
aMean (Standard deviation).
bNumber (%).
cMedian (Inter-quartile range).
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TABLE 2 | Groups’ pre-, post-, and follow up- raw/T-scores on each test/domain of the neuropsychological battery.
Time Domain/Test Experimental group Control group
Raw scores T scores Raw scores
Pre-assessment Screening 50.2 (5.3)
3Q 1.1 (1.1) 48.1 (11.1) 0.7 (0.9)
MMSE 27.6 (1.27) 5.3 (8.3) 27.5 (1.4)
IHDS 9.3 (1.7) 51.2 (10.5) 8.9 (1.6)
Speed Information Processing 49.8 (7.9)
TMT-A 45.9 (20.5) 49.8 (10.1) 44.9 (20.6)
STROOP-T 28.8 (11.4) 49.8 (11.1) 28.5 (9.4)
Learning & Memory 51.1 (7.7)
RAVLT-IR 39.7 (9.3) 51.6 (9.4) 36.5 (10.1)
RAVLT-DR 8.3 (2.8) 51.3 (8.9) 7.4 (3.5)
ROCF-DR 10.4 (5.2) 50.3 (11.1) 10.1 (4.3)
Abstraction/Executive Functioning 50.4 (5.4)
TOL 16.9 (1.5) 51.1 (10.2) 16.6 (1.5)
STROOP-E 2.75 (1.8) 50.8 (7.5) 3.2 (3)
TMT-B 149 (53.4) 52.9 (7.3) 190.7 (84.8)
FAB 13.3 (3.3) 49.9 (12.4) 13.3 (1.98)
ROCF-C 26.9 (5.5) 47.3 (10.6) 29.7 (4.6)
Verbal Fluency 51.9 (8.2)
FAS 28.6 (9.3) 53 (10.8) 23.3 (7.3)
VS 3.2 (0.6) 50.9 (10.5) 3.1 (0.5)
Attention/Working Memory 50.6 (5.3)
CORSI 3.6 (0.8) 47.8 (9.98) 3.9 (0.75)
DS 6.6 (1.9) 50.8 (9.6) 6.3 (2)
TMT-BA 103.1 (41.2) 53.2 (6.4) 144.4 (77.4)
Functional 49.6 (9.6)
IADL 7.2 (0.8) 49.6 (9.6) 7.2 (0.9)
Mental Health 47.7 (10.3)
PHQ-9 10.4 (6.8) 47.9 (10.5) 7.6 (6)
GAD-7 9.6 (6.2) 47.6 (10.9) 6.9 (4.9)
Post-assessment Screening 53.3 (4.2)
MMSE 28.2 (0.8) 52.6 (6.6) 27.5 (1.6)
IHDS 10 (0.7) 54 (4.6) 9.5 (1.8)
Speed Information Processing 51.3 (8.1)
TMT-A 46.4 (15) 50.8 (9.5) 48.9 (16.9)
STROOP-T 25.7 (10.9) 51.9 (9.97) 29.8 (10.9)
Learning and Memory 55.7 (6.2)
RAVLT-IR 44.5 (8.1) 55.4 (7.9) 33.4 (9.3)
RAVLT-DR 9.6 (3.5) 53.8 (9.8) 6.9 (3.2)
ROCF-DR 20.5 (4.5) 58.1 (6.8) 9.7 (3.1)
Abstraction/Executive Functioning 54.5 (2.8)
TOL 18 (0.9) 54.3 (5.9) 16.7 (1.7)
STROOP-E 1.6 (1.4) 54 (5.1) 3.8 (3.3)
TMT-B 128.6 (34.1) 52.2 (5.5) 155.9 (80.3)
FAB 15.8 (1.1) 56.5 (5.3) 13.1 (1.9)
ROCF-C 32.4 (1.7) 55.5 (5.2) 28.7 (3.6)
Verbal Fluency 56.7 (4.3)
FAS 37.5 (7.3) 56.8 (6.9) 23 (8.3)
VS 4 (0.5) 56.5 (6.8) 3.1 (0.6)
(Continued)
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TABLE 2 | Continued
Time Domain/Test Experimental group Control group
Raw scores T scores Raw scores
Attention/Working Memory 54.4 (4.9)
CORSI 4.7 (0.8) 53.4 (9.8) 4.1 (0.8)
DS 9 (1.5) 56.4 (6.3) 6.1 (2)
TMT-BA 82.2 (28.3) 53.4 (5.2) 119.1 (66.9)
Functional 53.9 (5.6)
IADL 7.8 (0.4) 53.9 (5.6) 7.2 (0.9)
Mental Health 49.5 (11.1)
PHQ-9 8.7 (6.3) 49.5 (10.9) 8.2 (5.4)
GAD-7 6.8 (5.8) 49.6 (11.7) 6.4 (4.2)
Follow up-assessment Screening 50 (5)
MMSE 28.8 (0.7) 50 (10)
IHDS 10.8 (0.9) 50 (10)
Speed Information Processing 50 (7.9)
TMT-A 38.2 (15.2) 50 (10)
STROOP-T 25.4 (8.5) 50 (10)
Learning and Memory 50 (7.9)
RAVLT-IR 49.8 (13.6) 50 (10)
RAVLT-DR 10.4 (2.6) 50 (10)
ROCF-DR 21.5 (5.1) 50 (10)
Abstraction/Executive Functioning 50 (3.6)
TOL 18.2 (0.7) 50 (10)
STROOP-E 1.9 (1.1) 50 (10)
TMT-B 114.4 (24.2) 50 (10)
FAB 16.1 (1) 50 (10)
ROCF-C 31.9 (2) 50 (10)
Verbal Fluency 50 (8.5)
FAS 38.2 (11.4) 50 (10)
VS 3.5 (0.6) 50 (10)
Attention/Working Memory 50 (6.9)
CORSI 4.7 (0.5) 50 (10)
DS 8.7 (1.2) 50 (10)
TMT-BA 73.8 (19.3) 50 (10)
Functional 50 (10)
IADL 7.9 (0.25) 50 (10)
Mental Health 50 (9.5)
PHQ-9 8.5 (4.8) 50 (10)
GAD-7 6.7 (3.6) 50 (10)
Scores are corrected for age, educational level and gender in the Italian population.
3Q, Simioni’s 3 question test, <1 pathological; MMSE, Mini Mental State Examination, <26 pathological; IHDS, International HIV Dementia Scale, <10 pathological; TMT-A, Trial
Making Test Part A, >68 pathological; STROOP-T, Stroop Time, ≥31.66 pathological; RAVLT-IR, Rey Auditory Verbal Learning Test Immediate Recall, <32.26 pathological; RAVLT-DR,
Rey Auditory Verbal Learning Test Delayed Recall, <5.8 pathological; ROCF-DR, Rey-Osterrieth Complex Figure Delayed Recall, ≤11.22 pathological; TOL, Tower of London, <15
pathological; STROOP-E, Stroop Errors, ≥2.81; TMT-B, Trial Making Test Part B, >177 pathological; FAB, Frontal Assessment Battery, <14.4 pathological; ROCF-C, Rey-Osterrieth
Complex Figure Copy, ≤30.04 pathological; FAS, Phonemic Fluency; <21.33 pathological; VS, Verbal Span, <3.5 pathological; CORSI, Corsi block-tapping test, <3.76 pathological;
DS, Digit Span, <8 pathological; TMT-BA, Trial Making Test Part BA, > 111 pathological; IADL, Instrumental Activity of Daily Living Questionnaire, ≤6 pathological; PHQ-9, Patient
Health Questionnaire, >15 pathological; GAD-7, Generalized Anxiety Disorder, >15 pathological.
Mean (Standard error).
test are reported in Table 2. Scores were corrected for age,
educational level and gender using Italian normative data. Since
the Grooved Pegboard Test has no standardization, it is not
reported.
Neuropsychological Battery
Initially, 220 consecutive HIV/AIDS patients were administered
three different screening tests of the neuropsychological battery in
a between-subjects randomized order:
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• Mini Mental State Examination (MMSE; Folstein et al., 1975)
• International HIV Dementia Scale (IHDS; Sacktor et al., 2005)
• Simioni’s 3 question test (3Q; Simioni et al., 2010)
Then, patients with a score below the cut off in MMSE,
and/or at three questions test, and/or at the IHDS were
administered in a between-subjects randomized order
the rest of the neuropsychological battery (N = 110)
composed by 19 tests covering seven different cognitive
domains:
• Speed of information processing
◦ Trail Making Test Part A (TMT-A, Giovagnoli et al., 1996)
◦ Stroop Color Test-Time (STROOP-T, Caffarra et al., 2002a)
• Learning and Memory
◦ Rey Auditory Verbal Learning Test Immediate Recall
(RAVLT-IR, Carlesimo et al., 1996)
◦ Rey Auditory Verbal Learning Test Delayed Recall (RAVLT-
IR, Carlesimo et al., 1996)
◦ Rey-Osterrieth Complex Figure Delayed Recall (ROCF-DR,
Caffarra et al., 2002b)
• Abstraction/Executive Functioning
◦ Tower of London simplified version (ToL; Allamanno et al.,
1987)
◦ Stroop Color Test-Errors (STROOP-E, Caffarra et al.,
2002a)
◦ Trail Making Test Part B (TMT-B, Giovagnoli et al., 1996)
◦ Frontal Assessment Battery (FAB, Appollonio et al., 2005)
◦ Rey-Osterrieth complex Figure Copy (ROCF-C, Caffarra
et al., 2002b)
• Verbal Fluency
◦ Phonemic Fluency (FAS, Carlesimo et al., 1995)
◦ Verbal Span (VS, Spinnler and Tognoni, 1987)
• Attention/Working Memory
◦ Corsi’s block-tapping Test (CORSI, Orsini et al., 1987)
◦ Digit Span (DS, Orsini and Laicardi, 1997)
◦ Trail Making Test Part BA (TMT-BA, Giovagnoli et al.,
1996)
• Motor
◦ Grooved Pegboard Test Dominant and non- dominant
hands (Heaton et al., 1991)
• Functional
◦ Instrumental Activity of Daily Living Questionnaire (IADL,
Lawton and Brody, 1969). This latter test was administered
to investigate 10 areas of autonomy in activities of daily
living: ability to use the phone, grocery shopping, preparing
meals, take care of the house, laundry, moving away from
home, assumption drugs, use of money, work ability, work
efficiency.
• Mental Health
◦ Patient Health Questionnaire (PHQ-9, Kroenke and Spitzer,
2002)
◦ Generalized Anxiety Disorder (GAD-7, Kroenke and
Spitzer, 2002)
Sixty of 110 tested patients (54%) were diagnosed withHAND (48
ANI, 10 MND, and 2 HAD). Participants (N = 32) were selected
among those with HAND based on specific eligibility criteria:
receiving antiretroviral therapy for at least 6 months, plasma
HIV RNA below 50 copies/mL for at least 6 months, CD4+ T
lymphocyte count above 350 cells/µ L from at least 6 months,
fluent Italian speaker, and absence of severe comorbidities,
including neurodegenerative or psychiatric disease, metabolic
encephalopathy, psychoactive drug use, alcohol use, or head
trauma.
Cognitive Rehabilitation Treatment
The cognitive rehabilitation protocol included both paper-
and-pencil and computer-based exercises and it was composed
of eight different exercises repeated in 36 sessions (around
50min each) over 4 months. The eight tests were administered
in a randomized-within subjects order. The protocol aimed
at improving with the different group of tests four cognitive
domains:
• Attention
◦ Time Pressure Management (Fasotti et al., 2000)
 Five minute paper-and-pencil exercise to improve
functional impairments related to slowed information
processing and complex attention. Patients learn
compensatory strategies as, for instance, allowing
sufficient time to manage a task
◦ Attention Process Training Task (Cicerone et al., 2005)
 Five minute paper-and-pencil exercise organized
hierarchically to improve different components of
attention: sustained, selective, alternating and divided
attention. Patients learn compensatory strategies as,
for instance, removing environmental distractors or
employing using cues to maintain attention
• Visual-verbal memory and learning
◦ COG.I.T.O. (open platform. ASPHI and San Camillo
Hospital, Turin
 Ten minute computer-based exercise to improve
attention/visual-spatial memory. Patients have to encode
daily-use objects in domestic environments (i.e., kitchen,
bedroom, garage). Then, objects disappear and they
have to put them back in their correct location, or
recognizing them among distractors and relocating
them, or writing their names and relocating them. From
session to session, the available time decreases whereas
the number of objects increases.
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◦ Errorless Learning (Ehlhardt et al., 2005)
 Five minute paper-and-pencil exercise providing
sufficient cues during training so that patients can only
give correct responses. Then, cues are progressively
sequentially reduced
◦ Process-Oriented Memory Learning (Huildebrandt et al.,
2006)
 Five minute paper-and-pencil exercise to improve
strategies adapted to different situations with memory
requirements (e.g., practice, managing interferences
between acquisition and recall, principles to optimize
memory performance)
• Executive Functioning and Working Memory
◦ Metacognitive Strategy Training (Kennedy et al., 2008)
 Five minute paper-and-pencil exercise to improve daily
problem-solving abilities (e.g., use of metacognitive
approaches incorporating emotional self-regulation
strategies which facilitates clear thinking)
◦ Goal Management Training (Levine et al., 2000)
 Five minute paper-and-pencil exercise to improve the
ability to stop and think about what one is doing,
identifying a specific goal, delineating the steps or
achieve a goal and evaluating the outcomes
• Metacognitive Awareness
◦ Increased Awareness (10min)
 Oneminute at the beginning of each session, 1min at the
end of each exercise for 10min to improve awareness of
neurocognitive deficits (Dams-O’Connor and Gordon,
2010).
RESULTS
Raw corrected scores on each neuropsychological test at pre
pre-, post-, and follow up- were standardized (T-score). When
necessary, the standard scores were reversed in order to keep the
interpretation of all tests in the same direction, namely higher
scores reflecting a better performance. Then the standard scores
were averaged within each domain.
In order to evaluate the efficacy of the cognitive rehabilitation
protocol, we performed a repeated measures ANOVA on
each domain of the neuropsychological battery with the mean
standard scores as dependent variables, TIME (two levels:
pre-assessment, post-assessment) as within-subjects factor, and
GROUP (two levels: experimental, control) as between-subjects
factor.
Respect to “Screening,” the TIME x group interaction resulted
to be significant [F(1, 30) = 7.05, p = 0.013]. Post-hoc
comparisons (Duncan) revealed that the two groups did not
differ at pre-assessment (experimental group: mean = 50.23,
SE = 1.32; control group: mean = 49.77, SE = 1.31), but
differed (p = 0.007) at post-assessment (experimental group:
mean= 53.3, SE= 1.74; control group: mean= 46.7, SE= 1.74);
see Figure 1. The analysis on “Speed information processing”
was not significant. As regards “Learning and memory,” the
TIME × GROUP interaction was significant [F(1, 30) = 31.58,
p < 0.0001]. Post-hoc comparisons (Duncan) revealed that the
two groups did not differ at pre-assessment (experimental group:
mean = 51.11, SE = 1.96; control group: mean = 48.89, SE =
1.95), but differed (p = 0.0002) at post-assessment (experimental
group: mean = 55.75, SE = 1.54; control group: mean = 44.24,
SE = 1.54) because the mean score of the experimental group
significantly (p = 0.0005) increased and the mean score of
the control group significantly (p = 0.0001) decreased (see
Figure 1). The TIME × GROUP interaction was significant
[F(1, 30) = 21.42, p < 0.0001 also for “Abstraction/Executive
Functioning.” Duncan post-hoc showed that the groups did not
differ at pre-assessment (experimental group: mean = 50.41,
SE = 1.9; control group: mean = 49.6, SE = 1.38), but differed
(p < 0.001) at post-assessment (experimental group: mean =
54.51, SE = 1.27; control group: mean = 47.48, SE = 1.27)
because the mean score of the experimental group significantly
(p = 0.003) increased, and the mean score of the control
group significantly (p = 0.003) decreased (see Figure 1). The
same was true for the “verbal fluency” in which the TIME ×
GROUP interaction was significant [F(1, 30) = 11.45, p =
0.002]. Duncan post-hoc analysis revealed that groups did not
differ at pre-assessment (experimental group: mean = 51.95,
SE = 1.91; control group: mean = 48.05, SE = 1.91), but
FIGURE 1 | Between-groups comparisons (domains) along time (pre- vs. post-assessment). Error bars represent standard errors. Asterisks indicate
significant comparisons, n.s. indicate non-significant comparisons.
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differed (p < 0.0001) at post-assessment (experimental group:
mean = 56.66, SE = 1.34; control group: mean = 43.34,
SE = 1.34) because the mean score of the experimental group
significantly (p = 0.02) increased and the mean score of
the control group significantly (p = 0.02) decreased (see
Figure 1). The TIME × GROUP interaction was significant
[F(1, 30) = 13.8, p = 0.001] also for “Attention/Working
memory.” Duncan post-hoc analysis revealed that groups did
not differ at pre-assessment (experimental group: mean = 50.62,
SE = 1.49; control group: mean = 49.38, SE = 1.49), but
differed (p = 0.0001) at post-assessment (experimental group:
mean = 54.42, SE = 1.22; control group: mean = 45.58,
SE = 1.22) because the mean score of the experimental group
significantly (p = 0.016) increased and the mean score of
the control group significantly (p = 0.016) decreased. The
same was true for “Functional” in which the TIME × GROUP
interaction was significant [F(1, 30) = 12.91, p = 0.001]. Duncan
post-hoc revealed that groups did not differ at pre-assessment
(experimental group: mean = 49.64, SE = 2.54; control group:
mean = 50.36, SE = 2.53), but differed (p = 0.042) at post-
assessment (experimental group: mean = 53.92, SE = 2.31;
control group: mean= 46.08, SE= 2.33) because the mean score
of the experimental group significantly (p = 0.021) increased and
the mean score of the control group significantly (p = 0.021)
decreased. The analysis on “Mental Health” was not significant.
In order to evaluate whether the treatment was able to
induce permanent effects, we performed in the experimental
group a within subject ANOVA on each domain of the
neuropsychological battery which improved from pre- to post
assessments. The mean standard scores were employed as
dependent variables, and TIME (three levels: pre-assessment,
post-assessment, follow up-assessment) as within-subjects factor.
The analysis on “Learning and Memory” (see Figure 2) resulted
to be significant [F(2, 30) = 8.92, p < 0.001]. Post-hoc
comparisons (Duncan) revealed that the mean score significantly
(p = 0.003) improved from pre- (mean = 51.1, SE = 1.94) to
post- (mean = 55.75, SE = 1.55) assessment and worsened (p <
0.001) from post- to follow up-assessment (mean = 50, SE =
2.1). Also the analysis on “Abstraction/executive functioning”
(see Figure 2) was significant [F(2,30) = 5, p = 0.008] with
the mean score significantly (p = 0.006) improved (Duncan)
from pre- (mean = 50.4, SE = 1.44) to post- (mean = 54.52,
SE = 0.7) assessment and worsened (p = 0.004) from post-
to follow up-assessment (mean = 50, SE = 0.9). The same
was true (see Figure 2) for “Verbal Fluency” [F(2, 30) = 5.5,
p = 0.01) with the mean score significantly (p = 0.03)
improved (Duncan) from pre- (mean = 51.95, SE = 2.06) to
post- (mean = 56.67, SE = 1.07) assessment and worsened
(p = 0.005) from post- to follow up-assessment (mean =
50, SE = 2.1). As regards “Attention/working memory” (see
Figure 2), the analysis resulted to be significant. However,
post-hoc comparisons (Duncan) revealed that the mean score
significantly (p = 0.03) improved from pre- (mean= 50.62, SE=
1.31) to post- (mean = 54.44, SE = 1.22) assessment but did not
change (p > 0.05) from post- to follow up-assessment (mean =
50, SE = 1.74). The analysis on “Functional” (see Figure 2) was
not significant (p > 0.05).
DISCUSSION
In the present study, we examined the efficacy of a cognitive
rehabilitation protocol that included both restorative and
FIGURE 2 | Experimental group trends (improved domains) along time (post- vs. follow up-assessment.
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compensatory approaches for treatment of HAND. Our results
show discordant clinical evolution in five out of eight domains
in participants who received the intervention compared with
those who did not: treated patients improved, untreated patients
worsened. Additionally, the improvement proved to be stable
over time in four of five domains.
Within the context of HIV, rehabilitation is a dynamic set
of activities that can benefit the disease as well as linked
social limitations and dysfunctions (Worthington et al., 2005).
With the graying of the HIV population, the demand for
rehabilitation services will likely increase in the near future
(O’Brien et al., 2014). Since a substantial number of HIV
patients have cognitive impairment (e.g., Heaton et al., 2010),
expansion in rehabilitation services should include cognitive
rehabilitation.
One definition of cognitive rehabilitation is a systematic,
functionally oriented set of therapeutic activities. Cognitive
improvement is achieved by both strengthening previously
learned behavioral patterns and establishing new, compensatory
ones (Bergquist and Malec, 1997). This is possible because of the
brain plasticity, the changes of brain organization that subserve
short- and long-term behavioral modifiability. These changes can
be structural (i.e., remodeling of the brain’s physical structures) or
physiological (i.e., dynamic adjustment of cellular processes such
as synapse formation that modulate conductance or resistance
to impulse transmission; see, for instance, Berlucchi, 2011).
These changes can include adaptation to novel environments,
maturation, different learning types, and compensatory changes
in response to functional loss (see, for instance, Berlucchi, 2011).
Successful cognitive rehabilitation treatment typically
targets different cognitive abilities, such as attention, memory,
perception, learning, and executive functioning. Metacognitive
awareness, emotional regulation, social skills and community
integration are other, important targets. The main aim of
cognitive rehabilitation is to significantly reduce the impact of
disease on daily living. More specific aims depend on the nature
and severity of the individual cognitive, behavioral, physical,
and emotional difficulties as well as on the specific individual
premorbid achievements (Dams-O’Connor and Gordon, 2010).
With HAND, HIV mainly affects fronto-striatal-
thalamocortical circuitry, often being associated with decreased
white matter volume (e.g., Thompson et al., 2005). As a
consequence, cognitive deficits can cover a wide range of
abilities. For instance, patients may develop impairments
of visual/verbal working memory (Martin et al., 2001) as a
consequence of central executive dysfunctions (Hinkin et al.,
2002). Additionally, patients may show working memory
impairments that can influence even higher-level cognitive
abilities and daily activities (Martin et al., 2004). Nonetheless,
HIV is frequently associated with difficulties of attentional
processes (Hinkin et al., 2002), which, in turn, may negatively
affect adherence to antiretroviral therapy (Levine et al., 2005,
2008). As a result, patients can experience multiple personal and
professional difficulties and are frequently unemployed (Heaton
et al., 1994; van Gorp et al., 2007).
In the present study, we aimed to maximize the effects of
a cognitive rehabilitation intervention by training patients in
both restorative (i.e., COG.I.T.O) and compensatory abilities
(Time Pressure Management, Attention Process Training
Task, Errorless Learning, Process-Oriented Memory Learning,
Metacognitive Strategy Training, Goal Management Training,
Increased Awareness). Each exercise was organized and
administered in different steps with progressively increasing
difficulty, suitable for gradual improvement of performance
and for learning of any targeted ability. As written above, we
found a significant improvement in the experimental, respect
to the control, from pre- to post-assessments in Learning and
memory, Abstraction/executive functioning, Verbal fluency,
Attention/working memory, and Daily functioning. The
improvement in Attention/working memory indirectly suggests
benefits for daily functioning (working memory) and medication
adherence (attention). The improvement in Learning and
memory could explain the improvements in self-reported IADLs
at post-assessment as well as the better work efficiency reported
by treated patients. In contrast, the control group significantly
worsened in the same domains.
At follow up-assessment, the cognitive improvement were
stable (i.e., no significant difference respect to post-assessment)
in two domains. It is worth noticing that previous long-term
(i.e., 5 months to 1 year) benefits of cognitive rehabilitation
(Tesar et al., 2005; Svendsen and Teasdale, 2006; Fink et al.,
2010; Stuifbergen et al., 2012), have been related to patients
continued use of learned strategies in ecological situations, as
well as to the relevance of the intervention to the patient’s
daily functioning (Cicerone et al., 2000). Then, patients of
experimental group used learned strategies in ecological contexts
of daily living. However, in the other three domains, the
experimental group’s performance significantly worsened (and,
indeed, this is also the overall trend). Broadly speaking, this is
not surprising but, rather, consistent with the fact that most
long-term follow up studies on the effects of acquired brain
injuries show also some persisting effects (Klonoff et al., 1993;
Dikmen et al., 2003; Wood and Rutterford, 2006). Additionally,
ARV neurotoxicity and the potential HIV activities within the
central nervous system acts against the cognitive rehabilitation
process. Indeed, thismight also explain, at least in part, the above-
mentioned fact that the control group worsened from pre- to
post-assessment.
Our study had several limitations. First, the sample size
is relatively small. Hence, further studies with larger samples
are required to validate the findings. Secondly, and more
importantly, the control group was administered standard of
care only but not a structured activity, raising the possibility
that repeating per se the cognitive rehabilitation protocol
might have a role in the improvement observed in the
experimental group. This possibility is countered by the
fact that benefit was not observed in all domains, which
would have been seen if the improvement was solely due to
practice. Still, this remains a limitation of our investigation
and future studies should employ active control activities
such as generalized compensatory cognitive training or low
cognitive demand computer activities (Weber et al., 2013).
Interestingly, those studies might address the effects of different
kind of interventions: restorative approaches vs. compensatory
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interventions, purely computer-based vs. purely paper-based.
Beyond the presence of a control condition, such strategies
would better enable proof of concept for the use of cognitive
rehabilitation in HAND.
In conclusion, our intervention was associated with better
cognitive performance. According to a recent call to action
(Weber et al., 2013), future studies should prioritize development
of specific cognitive rehabilitation interventions for HAND,
particularly with emphasis on two issues. First, while our center is
similar to other Italian centers, a specific battery of standardized
tests for HIV populations should be developed in Italy to
generalize our findings to different countries. Secondly, the
impact of cognitive rehabilitation on daily living, quality of life,
and medication adherence has to be clarified. Since unawareness
is in general a significant barrier to treatment (Ownsworth et al.,
2002) and since more than 50% of people with HIV have poor
insight of their cognitive deficits (Weber et al., 2013), more
specific measures and more sensitive interventions should be
developed.
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